166 related articles for article (PubMed ID: 24647989)
1. Hypovitaminosis D in primary hyperparathyroidism: to treat or not to treat? That is the question.
Minisola S; Romagnoli E; Scillitani A; Rao SD
J Endocrinol Invest; 2014 May; 37(5):413-4. PubMed ID: 24647989
[No Abstract] [Full Text] [Related]
2. Management of hypovitaminosis D in patients with primary hyperparathyroidism.
Rathi MS; Gonzalez S; Wright D; Ellis NR; Peacey SR
J Endocrinol Invest; 2014 May; 37(5):467-71. PubMed ID: 24515299
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D supplementation in African Americans: dose-response.
Brannon PM; Mayne ST; Murphy SP; Taylor CL
Am J Clin Nutr; 2014 Sep; 100(3):982-4. PubMed ID: 25142889
[No Abstract] [Full Text] [Related]
4. The vitamin D RDA for African American adults: higher than that for white persons?
Cashman KD
Am J Clin Nutr; 2014 Mar; 99(3):427-8. PubMed ID: 24452230
[No Abstract] [Full Text] [Related]
5. Reply to PM Brannon et al.
Ng K; Hollis BW; Giovannucci EL; Fuchs CS
Am J Clin Nutr; 2014 Sep; 100(3):984-6. PubMed ID: 25142890
[No Abstract] [Full Text] [Related]
6. Hyperammonaemia due to primary hyperparathyroidism-related renal tubular acidosis with incidental hypovitaminosis-D.
Bonnie R; Hu R
Eur J Intern Med; 2008 Dec; 19(8):e94-6. PubMed ID: 19046716
[No Abstract] [Full Text] [Related]
7. Effect of vitamin D supplementation on muscle energy phospho-metabolites: a ³¹P magnetic resonance spectroscopy-based pilot study.
Rana P; Marwaha RK; Kumar P; Narang A; Devi MM; Tripathi RP; Khushu S
Endocr Res; 2014; 39(4):152-6. PubMed ID: 24679100
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D and primary hyperparathyroidism: more insights into a complex relationship.
Walker MD; Bilezikian JP
Endocrine; 2017 Jan; 55(1):3-5. PubMed ID: 27858283
[No Abstract] [Full Text] [Related]
9. Assessment of 3-epi-25-hydroxyvitamin D levels during cholecalciferol supplementation in adults with chronic liver diseases.
Stokes CS; Volmer DA
Appl Physiol Nutr Metab; 2016 Dec; 41(12):1311-1317. PubMed ID: 27863206
[TBL] [Abstract][Full Text] [Related]
10. Cholecalciferol or Calcifediol in the Management of Vitamin D Deficiency.
Sosa Henríquez M; Gómez de Tejada Romero MJ
Nutrients; 2020 May; 12(6):. PubMed ID: 32486496
[TBL] [Abstract][Full Text] [Related]
11. The effect of cholecalciferol for lowering albuminuria in chronic kidney disease: a prospective controlled study.
Molina P; Górriz JL; Molina MD; Peris A; Beltrán S; Kanter J; Escudero V; Romero R; Pallardó LM
Nephrol Dial Transplant; 2014 Jan; 29(1):97-109. PubMed ID: 23975842
[TBL] [Abstract][Full Text] [Related]
12. A 12-week double-blind randomized clinical trial of vitamin D₃ supplementation on body fat mass in healthy overweight and obese women.
Salehpour A; Hosseinpanah F; Shidfar F; Vafa M; Razaghi M; Dehghani S; Hoshiarrad A; Gohari M
Nutr J; 2012 Sep; 11():78. PubMed ID: 22998754
[TBL] [Abstract][Full Text] [Related]
13. Effects of alendronate and vitamin D in patients with normocalcemic primary hyperparathyroidism.
Cesareo R; Di Stasio E; Vescini F; Campagna G; Cianni R; Pasqualini V; Romitelli F; Grimaldi F; Manfrini S; Palermo A
Osteoporos Int; 2015 Apr; 26(4):1295-302. PubMed ID: 25524023
[TBL] [Abstract][Full Text] [Related]
14. Cholecalciferol v. ergocalciferol for 25-hydroxyvitamin D (25(OH)D) repletion in chronic kidney disease: a randomised clinical trial.
Wetmore JB; Kimber C; Mahnken JD; Stubbs JR
Br J Nutr; 2016 Dec; 116(12):2074-2081. PubMed ID: 28065190
[TBL] [Abstract][Full Text] [Related]
15. A rational approach to vitamin D supplementation.
Boullata JI
Nutrition; 2012; 28(11-12):1204-5. PubMed ID: 23044166
[No Abstract] [Full Text] [Related]
16. Impact of cholecalciferol treatment on biomarkers of inflammation and myocardial structure in hemodialysis patients without hyperparathyroidism.
Bucharles S; Barberato SH; Stinghen AEM; Gruber B; Piekala L; Dambiski AC; Custodio MR; Pecoits-Filho R
J Ren Nutr; 2012 Mar; 22(2):284-291. PubMed ID: 21908203
[TBL] [Abstract][Full Text] [Related]
17. Impact of vitamin D replacement in patients with normocalcaemic and hypercalcaemic primary hyperparathyroidism and coexisting vitamin D deficiency.
Das G; Eligar V; Govindan J; Bondugulapati LN; Okosieme O; Davies S
Ann Clin Biochem; 2015 Jul; 52(Pt 4):462-9. PubMed ID: 25468998
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the effectiveness of cholecalciferol in long-term care elderly patients with hypovitaminosis D.
Shin M; Minden C
Consult Pharm; 2011 Feb; 26(2):101-7. PubMed ID: 21310707
[TBL] [Abstract][Full Text] [Related]
19. Cholecalciferol supplementation increases FGF23 in peritoneal dialysis patients with hypovitaminosis D: a randomized clinical trial.
Ramirez-Sandoval JC; Arvizu-Hernandez M; Cruz C; Vazquez-Cantu B; Rojas-Concha LJ; Tamez L; Reynerio F; Gomez FE; Correa-Rotter R
J Nephrol; 2019 Aug; 32(4):645-659. PubMed ID: 30888584
[TBL] [Abstract][Full Text] [Related]
20. A neonate with recurrent tetany: questions and answers.
Tseng MH; Chu SM; Lo FS; Lien RI; Cheng CJ; Lin SH
Pediatr Nephrol; 2016 May; 31(5):753, 755-7. PubMed ID: 26018119
[No Abstract] [Full Text] [Related]
[Next] [New Search]
